BF.B
53
-4
EA
50
14
ECL
74
2
WFC
57
5
AEE
63
2
AIV
65
3
HOG
39
3
SEE
34
4
YUM
45
2
XRAY
31
-10
NTRS
47
2
WU
12
-2
MCO
77
6
EMC
42
-3
APD
44
2
RRC
50
5
DE
39
-11
LNC
39
6
STT
48
6
MMC
67
2
BF.B
53
-4
EA
50
14
ECL
74
2
WFC
57
5
AEE
63
2
AIV
65
3
HOG
39
3
SEE
34
4
YUM
45
2
XRAY
31
-10
NTRS
47
2
WU
12
-2
MCO
77
6
EMC
42
-3
APD
44
2
RRC
50
5
DE
39
-11
LNC
39
6
STT
48
6
MMC
67
2
Financhill
Back

Summit Therapeutics Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
85

SMMT
Summit Therapeutics

Last Price:
26.20
Seasonality Move:
26.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Summit Therapeutics Price Quote

$26.20
-3.28 (-11.13%)
(Updated: September 17, 2024 at 6:55 PM ET)

Summit Therapeutics Key Stats

Buy
85
Summit Therapeutics (SMMT) is a Buy
Day range:
$25.61 - $29.09
52-week range:
$1.64 - $33.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21,654.49
P/B ratio:
111.06%
Volume:
14.6M
Avg. volume:
6.1M
1-year change:
1476.47%
Market cap:
$21.7B
Revenue:
$0
EPS:
$-0.19

How Much Does Summit Therapeutics Make?

Data Unavailable

Is Summit Therapeutics Growing As A Company?

Data Unavailable

Summit Therapeutics Stock Price Performance

What Is Summit Therapeutics 52-Week High & Low?

Summit Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Summit Therapeutics?

Is Summit Therapeutics Cash Flow Positive?

  • What Is SMMT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$97.5M
  • What Is Summit Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $207.2M
  • What Is Summit Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$123.1M

Summit Therapeutics Return On Invested Capital

Data Unavailable

Summit Therapeutics Earnings Date & Stock Price

Summit Therapeutics Competitors

  • Who Are Summit Therapeutics's Competitors?
    Below is a list of companies who compete with Summit Therapeutics or are related in some way:
    • Intelligent Bio Solutions Inc (INBS)
    • Merck & Co Inc (MRK)
    • Oncternal Therapeutics Inc (ONCT)
    • Relay Therapeutics Inc (RLAY)
    • Terns Pharmaceuticals Inc (TERN)

Summit Therapeutics Dividend Yield

Summit Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -44.76%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 29.65
Upside from Last Price: 0.56%

Major Shareholders

  • How many SMMT shares are owned by institutional investors?
    102.5M SMMT shares are owned by institutional investors
  • How many SMMT shares are owned by insiders?
    142.7M SMMT shares are owned by insiders